Teva Pharmaceuticals has chosen the Genedata‘s workflow platform to streamline the identification, engineering, and characterization of novel biopharmaceuticals drugs.  “We chose Genedata Biologics because its built-in business logic avoids costly software customization and it’s a proven off-the-shelf-product that can be implemented quickly and replace our current processes” said Dr. Adam Clarke, senior director, Teva Pharmaceuticals. “We also liked that it can be easily set-up to work ...